| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 11.822 | - | - | 60.649 | 75.243 | 31.665 | 71.114 | 105.728 | 140.990 |
| Total Income - EUR | - | 11.822 | - | - | 60.649 | 75.243 | 31.665 | 71.114 | 105.728 | 147.982 |
| Total Expenses - EUR | - | 15.255 | - | - | 22.281 | 32.888 | 24.917 | 63.046 | 63.740 | 121.457 |
| Gross Profit/Loss - EUR | - | -3.433 | - | - | 38.368 | 42.355 | 6.747 | 8.069 | 41.988 | 26.525 |
| Net Profit/Loss - EUR | - | -3.670 | - | - | 37.761 | 41.602 | 6.437 | 7.372 | 41.004 | 22.928 |
| Employees | - | 1 | - | - | 2 | 2 | 3 | 3 | 3 | 4 |
Check the financial reports for the company - Daluty Comprodexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.333 | - | - | 1.089 | 806 | 531 | 275 | 135 | 72.056 |
| Current Assets | - | 85.615 | - | - | 169.608 | 159.453 | 96.511 | 116.013 | 157.991 | 140.644 |
| Inventories | - | 15.238 | - | - | 7.369 | 7.229 | 35.354 | 45.826 | 29.566 | 18.373 |
| Receivables | - | 67.769 | - | - | 161.388 | 132.597 | 47.746 | 67.316 | 119.339 | 105.909 |
| Cash | - | 2.609 | - | - | 851 | 19.627 | 13.412 | 2.870 | 9.086 | 16.361 |
| Shareholders Funds | - | -21.584 | - | - | 19.856 | 61.082 | 66.165 | 73.741 | 114.522 | 136.810 |
| Social Capital | - | 45 | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 111.626 | - | - | 154.929 | 99.176 | 30.878 | 42.546 | 43.604 | 75.889 |
| Income in Advance | - | -2.227 | - | - | -2.107 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4321 - 4321" | |||||||||
| CAEN Financial Year |
4321
|
|||||||||
Comments - Daluty Comprodexim Srl